AVEO ACE is a comprehensive program dedicated to providing personalized support to patients with advanced RCC and their loved ones throughout the FOTIVDA treatment journey.
At AVEO ACE, we are dedicated to helping you understand the programs and resources available to you.
Once you and your healthcare professional have decided that FOTIVDA is right for you, an AVEO ACE Program Specialist is available to:
We know how difficult it can be to understand your health insurance coverage. AVEO ACE Program Specialists are here to help you better understand your insurance coverage for FOTIVDA and access therapy.
We care about helping you access your FOTIVDA treatment. AVEO ACE Program Specialists can help explore financial support options that may lower your out-of-pocket costs for FOTIVDA. If eligible, you may qualify for the:
The FOTIVDA® (tivozanib) Co-pay Card program provides eligible, commercially insured patients up to $25,000 per calendar year toward a patient’s FOTIVDA prescription costs. The FOTIVDA Co-pay Card program is not valid for uninsured patients. Annual and transaction limits apply. No other purchase is necessary.
Eligible patients must be prescribed FOTIVDA for an FDA-approved indication.
Eligible patients with a FOTIVDA prescription may pay as little as $0 toward their out-of-pocket costs. Patients must be 18 years or older to enroll and activate a co-pay card. The program can only be used by eligible residents of the United States, Puerto Rico, and Guam, and at participating pharmacies.
The offer does not constitute prescription drug coverage and is not intended to substitute for health insurance. The offer is not available to patients receiving any form of prescription coverage under any federal, state, or government-funded insurance program or where prohibited by law. Such programs include Medicare (including Medicare Part D and Medicare Advantage), Medicaid, TRICARE, Department of Defense, and Veterans Affairs programs. If at any time a patient begins receiving prescription drug coverage under any federal, state, or government-funded healthcare program, the patient will no longer be able to use the FOTIVDA Co-pay Card and the patient must call AVEO ACE patient support at 1-833-368-4832 to terminate participation.
Read More +Get FOTIVDA at no cost to you through the AVEO ACE Patient Assistance Program.
A patient must:
Other eligibility requirements and restrictions apply.
Download and print the AVEO ACE Enrollment Form to bring to your next doctor’s appointment. Your healthcare professional will need to complete the “Prescriber Information” section, and you will both need to sign the form. Then, your healthcare professional will submit it (along with copies of your prescription insurance cards) for approval.
Since it is important to take your FOTIVDA medication as prescribed, we have designed a unique and personalized nurse support program that may help you stay on track with your FOTIVDA treatment.
(1-833-368-4832)
Monday through Friday,
8 AM-8 PM ET.
OR
OR
the AVEO ACE enrollment form
and fax the completed form
to 1-888-920-2830.
has information on access and financial support.
provides helpful resources.
AVEO ACE makes no representation or guarantee concerning reimbursement or coverage for any service or item. Information provided through the AVEO ACE program does not constitute medical or legal advice and is not intended to be a substitute for a consultation with a licensed healthcare professional, legal counsel, or applicable third-party payer(s). AVEO ACE reserves the right to modify the program at any time without notice.
FOTIVDA® (tivozanib) is a prescription medicine used to treat adults with advanced kidney cancer (advanced renal cell carcinoma or RCC) that has been treated with 2 or more prior medicines and has come back or did not respond to treatment.
Possible serious side effects can occur with FOTIVDA. Call or see your healthcare provider right away if you develop:
High blood pressure (hypertension). High blood pressure may be severe, including a sudden, severe increase in your blood pressure (hypertensive crisis) that can
FOTIVDA® (tivozanib) is a prescription medicine used to treat adults with advanced kidney cancer (advanced renal cell carcinoma or RCC) that has been treated with 2 or more prior medicines and has come back or did not respond to treatment.
Possible serious side effects can occur with FOTIVDA. Call or see your healthcare provider right away if you develop:
High blood pressure (hypertension). High blood pressure may be severe, including a sudden, severe increase in your blood pressure (hypertensive crisis) that can lead to death. Your healthcare provider should check your blood pressure after 2 weeks and at least monthly, and may prescribe medicine to treat high blood pressure. You should check your blood pressure regularly and tell your healthcare provider if you have increased blood pressure or experience confusion, headaches, dizziness, chest pain, or shortness of breath.
Heart failure. Heart failure may be serious and sometimes lead to death. Your healthcare provider should check for symptoms of heart failure regularly, such as shortness of breath or swelling of your ankles.
Heart attack and blood clots in your veins or arteries. Blood clots may be serious and sometimes lead to death. Tell your healthcare provider or get emergency medical help right away if you have:
Bleeding problems. Bleeding may be serious and sometimes lead to death. Report or get medical help right away if you have:
Protein in your urine. Your healthcare provider should check your urine for protein before and during treatment.
Thyroid gland problems. Your healthcare provider should do blood tests to check your thyroid gland function before and during your treatment, and may prescribe medicine if you develop thyroid gland problems.
Risk of wound-healing problems. Wounds may not heal properly during treatment. Tell your healthcare provider if you plan to have surgery before starting or during treatment, including dental surgery.
Reversible Posterior Leukoencephalopathy Syndrome (RPLS). RPLS is a condition that can happen. Tell your healthcare provider right away if you have headaches, seizures, confusion, blindness or changes in vision, or difficulty thinking.
Allergic reactions to tartrazine (FD&C Yellow No. 5). FOTIVDA contains a dye called FD&C Yellow No. 5 (tartrazine) that may cause allergic-type reactions, including bronchial asthma, in certain people. This occurs most often in people who also are allergic to aspirin.
The most common side effects of FOTIVDA include:
Other side effects include vomiting and weakness or lack of energy. FOTIVDA may cause fertility problems in males and females, which may affect your ability to have a child.
Your healthcare provider may change your dose, temporarily stop, or permanently stop treatment with FOTIVDA if you have certain side effects.
These are not all of the possible side effects of FOTIVDA.
Before taking FOTIVDA, tell your healthcare provider about all your medical conditions, including if you:
Tell your healthcare provider about all the medicine you take and any new medicine, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Taking FOTIVDA with certain other medicines may affect how FOTIVDA works.
To report SUSPECTED ADVERSE REACTIONS, contact AVEO Pharmaceuticals, Inc. at 1-833-FOTIVDA (1-833-368-4832) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Please see the Patient Information in the full Prescribing Information for FOTIVDA® (tivozanib).